BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37122736)

  • 1. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of diagnostic hub genes related to neutrophils and infiltrating immune cell alterations in idiopathic pulmonary fibrosis.
    Lin Y; Lai X; Huang S; Pu L; Zeng Q; Wang Z; Huang W
    Front Immunol; 2023; 14():1078055. PubMed ID: 37334348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid metabolism-related genes in bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis.
    Lyu Y; Guo C; Zhang H
    Front Endocrinol (Lausanne); 2022; 13():1001563. PubMed ID: 36267568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of CXCL6 in secretory cells drives fibroblast collagen synthesis and is associated with increased mortality in idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Apel RM; Seeliger B; Schupp J; Li X; Sullivan DI; Sembrat J; Rojas M; Tabib T; Valenzi E; Lafyatis R; Mitash N; Hernandez Pineda R; Jawale C; Peroumal D; Biswas P; Tedrow J; Adams T; Kaminski N; Wuyts WA; McDyer JF; Gibson KF; Alder JK; Königshoff M; Zhang Y; Nouraie M; Prasse A; Kass DJ
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 37918852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis.
    Wu Z; Chen H; Ke S; Mo L; Qiu M; Zhu G; Zhu W; Liu L
    Sci Rep; 2023 Oct; 13(1):16559. PubMed ID: 37783761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of an endoplasmic reticulum stress-related gene prediction model and immune infiltration in idiopathic pulmonary fibrosis.
    Zhu H; Zhou A; Zhang M; Pan L; Wu X; Fu C; Gong L; Yang W; Liu D; Cheng Y
    Front Immunol; 2023; 14():1305025. PubMed ID: 38274787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of autophagy-related gene expression for predicting prognosis in patients with idiopathic pulmonary fibrosis.
    Huang G; Xu X; Ju C; Zhong N; He J; Tang XX
    Front Immunol; 2022; 13():997138. PubMed ID: 36211385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune-related genes in idiopathic pulmonary fibrosis based on bioinformatics and experimental verification.
    Li X; Huang Y; Ye N; He J
    Ann Palliat Med; 2021 Nov; 10(11):11598-11614. PubMed ID: 34872285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung gene expression and single cell analyses reveal two subsets of idiopathic pulmonary fibrosis (IPF) patients associated with different pathogenic mechanisms.
    Karman J; Wang J; Bodea C; Cao S; Levesque MC
    PLoS One; 2021; 16(3):e0248889. PubMed ID: 33755690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis-related genes and potential therapeutic drugs.
    Zhang Z; Guan Q; Tian Y; Shao X; Zhao P; Huang L; Li J
    BMC Pulm Med; 2023 Oct; 23(1):373. PubMed ID: 37794454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.
    Wang Y; Yella J; Chen J; McCormack FX; Madala SK; Jegga AG
    BMC Pulm Med; 2017 Oct; 17(1):133. PubMed ID: 29058630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of necroptosis-related prognostic genes and immune infiltration in idiopathic pulmonary fibrosis.
    Chen H; Xia Z; Qing B; Wang W; Gu L; Chen Y; Wang J; Yuan Y
    Front Immunol; 2023; 14():1119139. PubMed ID: 37051233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.
    DePianto DJ; Chandriani S; Abbas AR; Jia G; N'Diaye EN; Caplazi P; Kauder SE; Biswas S; Karnik SK; Ha C; Modrusan Z; Matthay MA; Kukreja J; Collard HR; Egen JG; Wolters PJ; Arron JR
    Thorax; 2015 Jan; 70(1):48-56. PubMed ID: 25217476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.
    Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C
    Front Genet; 2022; 13():865052. PubMed ID: 35559024
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.
    Qian W; Cai X; Qian Q; Zhang X
    Biomed Res Int; 2021; 2021():5545312. PubMed ID: 34285914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
    Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
    Chong DLW; Mikolasch TA; Sahota J; Rebeyrol C; Garthwaite HS; Booth HL; Heightman M; Denneny EK; José RJ; Khawaja AA; Duckworth A; Labelle M; Scotton CJ; Porter JC
    Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L487-L499. PubMed ID: 37643008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative bioinformatics and validation studies reveal KDM6B and its associated molecules as crucial modulators in Idiopathic Pulmonary Fibrosis.
    Chen A; Sun Z; Sun D; Huang M; Fang H; Zhang J; Qian G
    Front Immunol; 2023; 14():1183871. PubMed ID: 37275887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.
    Du W; Zhang T; Yang F; Gul A; Tang Z; Zhang H; Jiang S; Wang S; Dong J
    Phytomedicine; 2022 Aug; 103():154187. PubMed ID: 35667261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.